Psychologists in Montpelier, OH Accepting Medicare
2 Psychologists found. Showing 1 - 2
 John Dalrymple Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 1015 E Brown Rd, Montpelier, OH 43543 Phone: 419-485-6734 |
 Diane Lylnn Rehklau Psychologist - Adult Development & Aging Medicare: Not Enrolled in Medicare Practice Location: 10551 County Road K, Montpelier, OH 43543 Phone: 419-451-8256 |
News Archive
Cells can regenerate without becoming "younger"
It has long been thought that cells that regenerate tissue do so by regressing to a developmentally younger state. Now two University of Washington researchers have demonstrated that cells can regenerate without becoming "younger."
Researchers demonstrate a way to control excitation and contraction in cardiac muscle cells
By employing optogenetics, a new field that uses genetically altered cells to respond to light, and a tandem unit cell (TCU) strategy, researchers at Stony Brook University have demonstrated a way to control cell excitation and contraction in cardiac muscle cells, the details of which are published in the early online edition of Circulation: Arrhythmia & Electrophysiology: "Stimulating Cardiac Muscle by Light: Cardiac Optogenetics by Cell Delivery."
Counterfeit, substandard drugs threaten progress in controlling malaria in Africa, researchers report
"Hopes of controlling malaria in Africa could be wrecked by criminals who are circulating counterfeit and substandard drugs, threatening millions of lives, scientists" said in a study published in the Malaria Journal last month, the Guardian reports.
'Harm-minimization' approach can lead to high teen alcohol consumption
Allowing adolescents to drink alcohol under adult supervision does not appear to teach responsible drinking as teens get older. In fact, such a "harm-minimization" approach may actually lead to more drinking and alcohol-related consequences, according to a new study in the May 2011 issue of the Journal of Studies on Alcohol and Drugs.
FDA issues early communication about Xigris safety
The U.S. Food and Drug Administration has announced that it is working with the maker of Xigris (drotrecogin alfa activated), Eli Lilly and Company, to further evaluate the incidence of serious bleeding events and death in patients who receive Xigris, a drug used to treat severe sepsis (a blood stream infection).
› Verified 1 days ago